nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Temozolomide—melanoma	0.296	0.368	CiPCiCtD
Trabectedin—Alkylating Activity—Carmustine—melanoma	0.271	0.337	CiPCiCtD
Trabectedin—Alkylating Activity—Dacarbazine—melanoma	0.237	0.295	CiPCiCtD
Trabectedin—CYP2E1—Dacarbazine—melanoma	0.0277	0.348	CbGbCtD
Trabectedin—CYP3A4—Temozolomide—melanoma	0.02	0.251	CbGbCtD
Trabectedin—CYP2D6—Vemurafenib—melanoma	0.0172	0.216	CbGbCtD
Trabectedin—CYP3A4—Vemurafenib—melanoma	0.011	0.138	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—melanoma	0.00376	0.0472	CbGbCtD
Trabectedin—Alopecia—Vemurafenib—melanoma	0.000272	0.00477	CcSEcCtD
Trabectedin—Hepatotoxicity—Docetaxel—melanoma	0.00027	0.00473	CcSEcCtD
Trabectedin—Malnutrition—Vemurafenib—melanoma	0.000268	0.0047	CcSEcCtD
Trabectedin—Necrosis—Docetaxel—melanoma	0.000266	0.00466	CcSEcCtD
Trabectedin—Dysgeusia—Vemurafenib—melanoma	0.000263	0.0046	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000262	0.00459	CcSEcCtD
Trabectedin—Back pain—Vemurafenib—melanoma	0.000259	0.00455	CcSEcCtD
Trabectedin—Hepatic failure—Temozolomide—melanoma	0.000253	0.00444	CcSEcCtD
Trabectedin—Extravasation—Docetaxel—melanoma	0.000239	0.00419	CcSEcCtD
Trabectedin—Cough—Vemurafenib—melanoma	0.000234	0.0041	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Docetaxel—melanoma	0.000229	0.00402	CcSEcCtD
Trabectedin—Myalgia—Vemurafenib—melanoma	0.000228	0.004	CcSEcCtD
Trabectedin—Arthralgia—Vemurafenib—melanoma	0.000228	0.004	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000227	0.00398	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000227	0.00397	CcSEcCtD
Trabectedin—Pancytopenia—Bleomycin—melanoma	0.000221	0.00388	CcSEcCtD
Trabectedin—Infection—Vemurafenib—melanoma	0.000217	0.00381	CcSEcCtD
Trabectedin—Nervous system disorder—Vemurafenib—melanoma	0.000215	0.00376	CcSEcCtD
Trabectedin—Hypokalaemia—Carmustine—melanoma	0.000214	0.00376	CcSEcCtD
Trabectedin—Skin disorder—Vemurafenib—melanoma	0.000213	0.00373	CcSEcCtD
Trabectedin—Dehydration—Temozolomide—melanoma	0.000212	0.00371	CcSEcCtD
Trabectedin—Weight decreased—Bleomycin—melanoma	0.000211	0.0037	CcSEcCtD
Trabectedin—Pulmonary embolism—Docetaxel—melanoma	0.000209	0.00366	CcSEcCtD
Trabectedin—Injection site reaction—Docetaxel—melanoma	0.000207	0.00363	CcSEcCtD
Trabectedin—Hypokalaemia—Temozolomide—melanoma	0.000207	0.00363	CcSEcCtD
Trabectedin—Pancytopenia—Dactinomycin—melanoma	0.000207	0.00362	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000205	0.00359	CcSEcCtD
Trabectedin—Hypotension—Vemurafenib—melanoma	0.000205	0.00359	CcSEcCtD
Trabectedin—Neutropenia—Dactinomycin—melanoma	0.000203	0.00357	CcSEcCtD
Trabectedin—Stomatitis—Bleomycin—melanoma	0.000203	0.00355	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Temozolomide—melanoma	0.000201	0.00352	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000199	0.0035	CcSEcCtD
Trabectedin—Pancytopenia—Carmustine—melanoma	0.000193	0.00339	CcSEcCtD
Trabectedin—Neutropenia—Carmustine—melanoma	0.00019	0.00334	CcSEcCtD
Trabectedin—Decreased appetite—Vemurafenib—melanoma	0.00019	0.00334	CcSEcCtD
Trabectedin—Stomatitis—Dactinomycin—melanoma	0.000189	0.00331	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000189	0.00331	CcSEcCtD
Trabectedin—Fatigue—Vemurafenib—melanoma	0.000189	0.00331	CcSEcCtD
Trabectedin—Haemoglobin—Bleomycin—melanoma	0.000188	0.00329	CcSEcCtD
Trabectedin—Constipation—Vemurafenib—melanoma	0.000187	0.00328	CcSEcCtD
Trabectedin—Pancytopenia—Temozolomide—melanoma	0.000187	0.00327	CcSEcCtD
Trabectedin—Haemorrhage—Bleomycin—melanoma	0.000187	0.00327	CcSEcCtD
Trabectedin—Pulmonary oedema—Docetaxel—melanoma	0.000186	0.00325	CcSEcCtD
Trabectedin—Neutropenia—Temozolomide—melanoma	0.000184	0.00322	CcSEcCtD
Trabectedin—Agranulocytosis—Dactinomycin—melanoma	0.000181	0.00317	CcSEcCtD
Trabectedin—Sepsis—Docetaxel—melanoma	0.000181	0.00317	CcSEcCtD
Trabectedin—Weight decreased—Temozolomide—melanoma	0.000178	0.00312	CcSEcCtD
Trabectedin—Stomatitis—Carmustine—melanoma	0.000177	0.0031	CcSEcCtD
Trabectedin—Infestation NOS—Temozolomide—melanoma	0.000175	0.00307	CcSEcCtD
Trabectedin—Infestation—Temozolomide—melanoma	0.000175	0.00307	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000174	0.00305	CcSEcCtD
Trabectedin—Flushing—Bleomycin—melanoma	0.000173	0.00304	CcSEcCtD
Trabectedin—Body temperature increased—Vemurafenib—melanoma	0.000173	0.00303	CcSEcCtD
Trabectedin—Stomatitis—Temozolomide—melanoma	0.000171	0.003	CcSEcCtD
Trabectedin—Hepatic failure—Docetaxel—melanoma	0.000168	0.00295	CcSEcCtD
Trabectedin—Hepatobiliary disease—Temozolomide—melanoma	0.000166	0.00291	CcSEcCtD
Trabectedin—Alopecia—Bleomycin—melanoma	0.000165	0.00289	CcSEcCtD
Trabectedin—Haemoglobin—Carmustine—melanoma	0.000164	0.00287	CcSEcCtD
Trabectedin—Haemorrhage—Carmustine—melanoma	0.000163	0.00286	CcSEcCtD
Trabectedin—Flushing—Dactinomycin—melanoma	0.000162	0.00283	CcSEcCtD
Trabectedin—Hypersensitivity—Vemurafenib—melanoma	0.000161	0.00283	CcSEcCtD
Trabectedin—Oedema peripheral—Carmustine—melanoma	0.000161	0.00281	CcSEcCtD
Trabectedin—Connective tissue disorder—Carmustine—melanoma	0.00016	0.00281	CcSEcCtD
Trabectedin—Haemoglobin—Temozolomide—melanoma	0.000158	0.00277	CcSEcCtD
Trabectedin—Haemorrhage—Temozolomide—melanoma	0.000157	0.00276	CcSEcCtD
Trabectedin—Asthenia—Vemurafenib—melanoma	0.000157	0.00275	CcSEcCtD
Trabectedin—Oedema peripheral—Temozolomide—melanoma	0.000155	0.00272	CcSEcCtD
Trabectedin—Connective tissue disorder—Temozolomide—melanoma	0.000155	0.00271	CcSEcCtD
Trabectedin—Alopecia—Dactinomycin—melanoma	0.000154	0.0027	CcSEcCtD
Trabectedin—Flushing—Carmustine—melanoma	0.000151	0.00265	CcSEcCtD
Trabectedin—Anaemia—Bleomycin—melanoma	0.00015	0.00263	CcSEcCtD
Trabectedin—Diarrhoea—Vemurafenib—melanoma	0.00015	0.00263	CcSEcCtD
Trabectedin—Flushing—Temozolomide—melanoma	0.000146	0.00256	CcSEcCtD
Trabectedin—Leukopenia—Bleomycin—melanoma	0.000145	0.00255	CcSEcCtD
Trabectedin—Dizziness—Vemurafenib—melanoma	0.000145	0.00254	CcSEcCtD
Trabectedin—Alopecia—Carmustine—melanoma	0.000144	0.00252	CcSEcCtD
Trabectedin—Angiopathy—Temozolomide—melanoma	0.000143	0.0025	CcSEcCtD
Trabectedin—Mental disorder—Carmustine—melanoma	0.000143	0.0025	CcSEcCtD
Trabectedin—Mediastinal disorder—Temozolomide—melanoma	0.000142	0.00249	CcSEcCtD
Trabectedin—Malnutrition—Carmustine—melanoma	0.000142	0.00249	CcSEcCtD
Trabectedin—Cough—Bleomycin—melanoma	0.000142	0.00249	CcSEcCtD
Trabectedin—Dehydration—Docetaxel—melanoma	0.000141	0.00247	CcSEcCtD
Trabectedin—Anaemia—Dactinomycin—melanoma	0.00014	0.00246	CcSEcCtD
Trabectedin—Vomiting—Vemurafenib—melanoma	0.000139	0.00244	CcSEcCtD
Trabectedin—Alopecia—Temozolomide—melanoma	0.000139	0.00244	CcSEcCtD
Trabectedin—Myalgia—Bleomycin—melanoma	0.000138	0.00243	CcSEcCtD
Trabectedin—Abdominal pain upper—Docetaxel—melanoma	0.000138	0.00242	CcSEcCtD
Trabectedin—Rash—Vemurafenib—melanoma	0.000138	0.00242	CcSEcCtD
Trabectedin—Mental disorder—Temozolomide—melanoma	0.000138	0.00242	CcSEcCtD
Trabectedin—Dermatitis—Vemurafenib—melanoma	0.000138	0.00242	CcSEcCtD
Trabectedin—Back pain—Carmustine—melanoma	0.000137	0.00241	CcSEcCtD
Trabectedin—Headache—Vemurafenib—melanoma	0.000137	0.0024	CcSEcCtD
Trabectedin—Malnutrition—Temozolomide—melanoma	0.000137	0.0024	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000136	0.00239	CcSEcCtD
Trabectedin—Leukopenia—Dactinomycin—melanoma	0.000136	0.00238	CcSEcCtD
Trabectedin—Dysgeusia—Temozolomide—melanoma	0.000134	0.00235	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Docetaxel—melanoma	0.000133	0.00234	CcSEcCtD
Trabectedin—Oedema—Bleomycin—melanoma	0.000133	0.00232	CcSEcCtD
Trabectedin—Back pain—Temozolomide—melanoma	0.000133	0.00232	CcSEcCtD
Trabectedin—Infection—Bleomycin—melanoma	0.000132	0.00231	CcSEcCtD
Trabectedin—Anaemia—Carmustine—melanoma	0.000131	0.0023	CcSEcCtD
Trabectedin—Nausea—Vemurafenib—melanoma	0.00013	0.00228	CcSEcCtD
Trabectedin—Thrombocytopenia—Bleomycin—melanoma	0.00013	0.00228	CcSEcCtD
Trabectedin—Myalgia—Dactinomycin—melanoma	0.000129	0.00226	CcSEcCtD
Trabectedin—Leukopenia—Carmustine—melanoma	0.000127	0.00223	CcSEcCtD
Trabectedin—Anaemia—Temozolomide—melanoma	0.000127	0.00222	CcSEcCtD
Trabectedin—Anorexia—Bleomycin—melanoma	0.000126	0.00222	CcSEcCtD
Trabectedin—Pancytopenia—Docetaxel—melanoma	0.000124	0.00218	CcSEcCtD
Trabectedin—Hypotension—Bleomycin—melanoma	0.000124	0.00217	CcSEcCtD
Trabectedin—Oedema—Dactinomycin—melanoma	0.000124	0.00217	CcSEcCtD
Trabectedin—Infection—Dactinomycin—melanoma	0.000123	0.00215	CcSEcCtD
Trabectedin—Leukopenia—Temozolomide—melanoma	0.000123	0.00215	CcSEcCtD
Trabectedin—Neutropenia—Docetaxel—melanoma	0.000122	0.00214	CcSEcCtD
Trabectedin—Thrombocytopenia—Dactinomycin—melanoma	0.000121	0.00212	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000121	0.00212	CcSEcCtD
Trabectedin—Myalgia—Carmustine—melanoma	0.000121	0.00212	CcSEcCtD
Trabectedin—Cough—Temozolomide—melanoma	0.00012	0.0021	CcSEcCtD
Trabectedin—Paraesthesia—Bleomycin—melanoma	0.000119	0.00209	CcSEcCtD
Trabectedin—Weight decreased—Docetaxel—melanoma	0.000118	0.00207	CcSEcCtD
Trabectedin—Dyspnoea—Bleomycin—melanoma	0.000118	0.00207	CcSEcCtD
Trabectedin—Anorexia—Dactinomycin—melanoma	0.000118	0.00207	CcSEcCtD
Trabectedin—Myalgia—Temozolomide—melanoma	0.000117	0.00205	CcSEcCtD
Trabectedin—Arthralgia—Temozolomide—melanoma	0.000117	0.00205	CcSEcCtD
Trabectedin—Infestation NOS—Docetaxel—melanoma	0.000117	0.00204	CcSEcCtD
Trabectedin—Infestation—Docetaxel—melanoma	0.000117	0.00204	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000116	0.00203	CcSEcCtD
Trabectedin—Oedema—Carmustine—melanoma	0.000116	0.00203	CcSEcCtD
Trabectedin—Decreased appetite—Bleomycin—melanoma	0.000115	0.00202	CcSEcCtD
Trabectedin—Infection—Carmustine—melanoma	0.000115	0.00202	CcSEcCtD
Trabectedin—Stomatitis—Docetaxel—melanoma	0.000114	0.00199	CcSEcCtD
Trabectedin—Jaundice—Docetaxel—melanoma	0.000114	0.00199	CcSEcCtD
Trabectedin—Thrombocytopenia—Carmustine—melanoma	0.000113	0.00199	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000113	0.00198	CcSEcCtD
Trabectedin—Oedema—Temozolomide—melanoma	0.000112	0.00196	CcSEcCtD
Trabectedin—Infection—Temozolomide—melanoma	0.000111	0.00195	CcSEcCtD
Trabectedin—Anorexia—Carmustine—melanoma	0.00011	0.00193	CcSEcCtD
Trabectedin—Hepatobiliary disease—Docetaxel—melanoma	0.00011	0.00193	CcSEcCtD
Trabectedin—Nervous system disorder—Temozolomide—melanoma	0.00011	0.00192	CcSEcCtD
Trabectedin—Thrombocytopenia—Temozolomide—melanoma	0.00011	0.00192	CcSEcCtD
Trabectedin—Agranulocytosis—Docetaxel—melanoma	0.000109	0.00191	CcSEcCtD
Trabectedin—Skin disorder—Temozolomide—melanoma	0.000109	0.0019	CcSEcCtD
Trabectedin—Hypotension—Carmustine—melanoma	0.000108	0.0019	CcSEcCtD
Trabectedin—Decreased appetite—Dactinomycin—melanoma	0.000108	0.00188	CcSEcCtD
Trabectedin—Fatigue—Dactinomycin—melanoma	0.000107	0.00187	CcSEcCtD
Trabectedin—Anorexia—Temozolomide—melanoma	0.000107	0.00187	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Carmustine—melanoma	0.000105	0.00185	CcSEcCtD
Trabectedin—Haemoglobin—Docetaxel—melanoma	0.000105	0.00184	CcSEcCtD
Trabectedin—Body temperature increased—Bleomycin—melanoma	0.000105	0.00184	CcSEcCtD
Trabectedin—Haemorrhage—Docetaxel—melanoma	0.000105	0.00184	CcSEcCtD
Trabectedin—Insomnia—Carmustine—melanoma	0.000105	0.00184	CcSEcCtD
Trabectedin—Paraesthesia—Carmustine—melanoma	0.000104	0.00182	CcSEcCtD
Trabectedin—Dyspnoea—Carmustine—melanoma	0.000103	0.00181	CcSEcCtD
Trabectedin—Oedema peripheral—Docetaxel—melanoma	0.000103	0.00181	CcSEcCtD
Trabectedin—Connective tissue disorder—Docetaxel—melanoma	0.000103	0.0018	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000102	0.00179	CcSEcCtD
Trabectedin—Insomnia—Temozolomide—melanoma	0.000101	0.00177	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dactinomycin—melanoma	0.000101	0.00177	CcSEcCtD
Trabectedin—Decreased appetite—Carmustine—melanoma	0.000101	0.00176	CcSEcCtD
Trabectedin—Paraesthesia—Temozolomide—melanoma	0.0001	0.00176	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Carmustine—melanoma	9.99e-05	0.00175	CcSEcCtD
Trabectedin—Dyspnoea—Temozolomide—melanoma	9.97e-05	0.00175	CcSEcCtD
Trabectedin—Constipation—Carmustine—melanoma	9.9e-05	0.00174	CcSEcCtD
Trabectedin—Dyspepsia—Temozolomide—melanoma	9.85e-05	0.00173	CcSEcCtD
Trabectedin—Body temperature increased—Dactinomycin—melanoma	9.78e-05	0.00171	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—melanoma	9.78e-05	0.00171	CcSEcCtD
Trabectedin—Hypersensitivity—Bleomycin—melanoma	9.77e-05	0.00171	CcSEcCtD
Trabectedin—Decreased appetite—Temozolomide—melanoma	9.72e-05	0.0017	CcSEcCtD
Trabectedin—Flushing—Docetaxel—melanoma	9.72e-05	0.0017	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Temozolomide—melanoma	9.66e-05	0.00169	CcSEcCtD
Trabectedin—Fatigue—Temozolomide—melanoma	9.64e-05	0.00169	CcSEcCtD
Trabectedin—Constipation—Temozolomide—melanoma	9.57e-05	0.00168	CcSEcCtD
Trabectedin—Asthenia—Bleomycin—melanoma	9.52e-05	0.00167	CcSEcCtD
Trabectedin—Angiopathy—Docetaxel—melanoma	9.5e-05	0.00167	CcSEcCtD
Trabectedin—Gastrointestinal pain—Carmustine—melanoma	9.47e-05	0.00166	CcSEcCtD
Trabectedin—Mediastinal disorder—Docetaxel—melanoma	9.44e-05	0.00165	CcSEcCtD
Trabectedin—Alopecia—Docetaxel—melanoma	9.25e-05	0.00162	CcSEcCtD
Trabectedin—Mental disorder—Docetaxel—melanoma	9.17e-05	0.00161	CcSEcCtD
Trabectedin—Abdominal pain—Carmustine—melanoma	9.15e-05	0.0016	CcSEcCtD
Trabectedin—Body temperature increased—Carmustine—melanoma	9.15e-05	0.0016	CcSEcCtD
Trabectedin—Gastrointestinal pain—Temozolomide—melanoma	9.15e-05	0.0016	CcSEcCtD
Trabectedin—Malnutrition—Docetaxel—melanoma	9.12e-05	0.0016	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—melanoma	9.11e-05	0.0016	CcSEcCtD
Trabectedin—Dysgeusia—Docetaxel—melanoma	8.93e-05	0.00156	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—melanoma	8.87e-05	0.00156	CcSEcCtD
Trabectedin—Abdominal pain—Temozolomide—melanoma	8.84e-05	0.00155	CcSEcCtD
Trabectedin—Body temperature increased—Temozolomide—melanoma	8.84e-05	0.00155	CcSEcCtD
Trabectedin—Back pain—Docetaxel—melanoma	8.82e-05	0.00155	CcSEcCtD
Trabectedin—Hypersensitivity—Carmustine—melanoma	8.53e-05	0.0015	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—melanoma	8.46e-05	0.00148	CcSEcCtD
Trabectedin—Vomiting—Bleomycin—melanoma	8.43e-05	0.00148	CcSEcCtD
Trabectedin—Anaemia—Docetaxel—melanoma	8.43e-05	0.00148	CcSEcCtD
Trabectedin—Rash—Bleomycin—melanoma	8.36e-05	0.00147	CcSEcCtD
Trabectedin—Dermatitis—Bleomycin—melanoma	8.35e-05	0.00146	CcSEcCtD
Trabectedin—Asthenia—Carmustine—melanoma	8.31e-05	0.00146	CcSEcCtD
Trabectedin—Hypersensitivity—Temozolomide—melanoma	8.24e-05	0.00144	CcSEcCtD
Trabectedin—Syncope—Docetaxel—melanoma	8.17e-05	0.00143	CcSEcCtD
Trabectedin—Leukopenia—Docetaxel—melanoma	8.16e-05	0.00143	CcSEcCtD
Trabectedin—Asthenia—Temozolomide—melanoma	8.03e-05	0.00141	CcSEcCtD
Trabectedin—Loss of consciousness—Docetaxel—melanoma	8.01e-05	0.0014	CcSEcCtD
Trabectedin—Cough—Docetaxel—melanoma	7.95e-05	0.00139	CcSEcCtD
Trabectedin—Diarrhoea—Carmustine—melanoma	7.92e-05	0.00139	CcSEcCtD
Trabectedin—Nausea—Bleomycin—melanoma	7.88e-05	0.00138	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—melanoma	7.86e-05	0.00138	CcSEcCtD
Trabectedin—Rash—Dactinomycin—melanoma	7.8e-05	0.00137	CcSEcCtD
Trabectedin—Arthralgia—Docetaxel—melanoma	7.76e-05	0.00136	CcSEcCtD
Trabectedin—Myalgia—Docetaxel—melanoma	7.76e-05	0.00136	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	7.71e-05	0.00135	CcSEcCtD
Trabectedin—Dizziness—Carmustine—melanoma	7.66e-05	0.00134	CcSEcCtD
Trabectedin—Diarrhoea—Temozolomide—melanoma	7.65e-05	0.00134	CcSEcCtD
Trabectedin—Oedema—Docetaxel—melanoma	7.44e-05	0.0013	CcSEcCtD
Trabectedin—Dizziness—Temozolomide—melanoma	7.4e-05	0.0013	CcSEcCtD
Trabectedin—Infection—Docetaxel—melanoma	7.39e-05	0.0013	CcSEcCtD
Trabectedin—Vomiting—Carmustine—melanoma	7.36e-05	0.00129	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—melanoma	7.35e-05	0.00129	CcSEcCtD
Trabectedin—Shock—Docetaxel—melanoma	7.32e-05	0.00128	CcSEcCtD
Trabectedin—Rash—Carmustine—melanoma	7.3e-05	0.00128	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—melanoma	7.3e-05	0.00128	CcSEcCtD
Trabectedin—Dermatitis—Carmustine—melanoma	7.29e-05	0.00128	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—melanoma	7.28e-05	0.00128	CcSEcCtD
Trabectedin—Headache—Carmustine—melanoma	7.25e-05	0.00127	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—melanoma	7.23e-05	0.00127	CcSEcCtD
Trabectedin—Vomiting—Temozolomide—melanoma	7.11e-05	0.00125	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—melanoma	7.09e-05	0.00124	CcSEcCtD
Trabectedin—Rash—Temozolomide—melanoma	7.05e-05	0.00124	CcSEcCtD
Trabectedin—Dermatitis—Temozolomide—melanoma	7.05e-05	0.00124	CcSEcCtD
Trabectedin—Headache—Temozolomide—melanoma	7.01e-05	0.00123	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—melanoma	6.95e-05	0.00122	CcSEcCtD
Trabectedin—Nausea—Carmustine—melanoma	6.88e-05	0.00121	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—melanoma	6.78e-05	0.00119	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—melanoma	6.73e-05	0.00118	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—melanoma	6.68e-05	0.00117	CcSEcCtD
Trabectedin—Nausea—Temozolomide—melanoma	6.64e-05	0.00116	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—melanoma	6.63e-05	0.00116	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—melanoma	6.55e-05	0.00115	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—melanoma	6.47e-05	0.00113	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—melanoma	6.42e-05	0.00113	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—melanoma	6.41e-05	0.00112	CcSEcCtD
Trabectedin—Constipation—Docetaxel—melanoma	6.36e-05	0.00112	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—melanoma	6.08e-05	0.00107	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—melanoma	5.88e-05	0.00103	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—melanoma	5.88e-05	0.00103	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—melanoma	5.48e-05	0.000961	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—melanoma	5.34e-05	0.000936	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—melanoma	5.09e-05	0.000892	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—melanoma	4.92e-05	0.000862	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—melanoma	4.73e-05	0.000829	CcSEcCtD
Trabectedin—Rash—Docetaxel—melanoma	4.69e-05	0.000822	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—melanoma	4.69e-05	0.000821	CcSEcCtD
Trabectedin—Headache—Docetaxel—melanoma	4.66e-05	0.000817	CcSEcCtD
Trabectedin—Nausea—Docetaxel—melanoma	4.42e-05	0.000775	CcSEcCtD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.09e-06	5.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HPSE—melanoma	3.07e-06	5.1e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—melanoma	3.07e-06	5.1e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NOTCH1—melanoma	3.04e-06	5.05e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP17A1—melanoma	3.02e-06	5.02e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CUBN—melanoma	3.01e-06	5.01e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CASP8—melanoma	3e-06	4.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.98e-06	4.96e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB4—melanoma	2.98e-06	4.96e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.98e-06	4.95e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CD80—melanoma	2.98e-06	4.95e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK1—melanoma	2.98e-06	4.95e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—melanoma	2.98e-06	4.94e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KIT—melanoma	2.97e-06	4.94e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—APC—melanoma	2.97e-06	4.94e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—melanoma	2.96e-06	4.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN2B—melanoma	2.96e-06	4.91e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.94e-06	4.89e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGF—melanoma	2.94e-06	4.88e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CSPG4—melanoma	2.91e-06	4.84e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BSG—melanoma	2.91e-06	4.84e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SDHD—melanoma	2.91e-06	4.84e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—melanoma	2.87e-06	4.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD86—melanoma	2.86e-06	4.75e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—melanoma	2.86e-06	4.75e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNA11—melanoma	2.85e-06	4.74e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAP2K1—melanoma	2.85e-06	4.74e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EDN1—melanoma	2.84e-06	4.71e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CD—melanoma	2.83e-06	4.7e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPAM—melanoma	2.82e-06	4.68e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—melanoma	2.81e-06	4.67e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—BRAF—melanoma	2.8e-06	4.64e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—FASN—melanoma	2.79e-06	4.64e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP17A1—melanoma	2.78e-06	4.62e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—melanoma	2.78e-06	4.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CSF2—melanoma	2.77e-06	4.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGF1—melanoma	2.77e-06	4.61e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP17A1—melanoma	2.76e-06	4.58e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC5A5—melanoma	2.75e-06	4.56e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.75e-06	4.56e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.72e-06	4.51e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—melanoma	2.72e-06	4.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—E2F1—melanoma	2.71e-06	4.51e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGF2—melanoma	2.71e-06	4.5e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—melanoma	2.71e-06	4.5e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—melanoma	2.7e-06	4.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFRA—melanoma	2.69e-06	4.46e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.68e-06	4.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ITGB3—melanoma	2.66e-06	4.42e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PRKCA—melanoma	2.66e-06	4.42e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—melanoma	2.66e-06	4.41e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CD44—melanoma	2.65e-06	4.41e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAQ—melanoma	2.65e-06	4.41e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAP2K1—melanoma	2.63e-06	4.37e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNA11—melanoma	2.62e-06	4.36e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CG—melanoma	2.62e-06	4.35e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CD—melanoma	2.61e-06	4.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SPP1—melanoma	2.61e-06	4.33e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNA11—melanoma	2.6e-06	4.32e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAP2K2—melanoma	2.6e-06	4.32e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.6e-06	4.32e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—melanoma	2.59e-06	4.3e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—melanoma	2.58e-06	4.29e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2—melanoma	2.57e-06	4.28e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.57e-06	4.28e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—FASN—melanoma	2.57e-06	4.27e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNG—melanoma	2.55e-06	4.24e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—FASN—melanoma	2.55e-06	4.23e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1B1—melanoma	2.54e-06	4.22e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MDM2—melanoma	2.54e-06	4.21e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—melanoma	2.53e-06	4.2e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC5A5—melanoma	2.53e-06	4.2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC5A5—melanoma	2.5e-06	4.16e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—FGF2—melanoma	2.5e-06	4.16e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—melanoma	2.5e-06	4.15e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PRKCA—melanoma	2.5e-06	4.15e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—melanoma	2.48e-06	4.12e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ERCC2—melanoma	2.48e-06	4.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—melanoma	2.47e-06	4.11e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CB—melanoma	2.47e-06	4.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RAC1—melanoma	2.47e-06	4.09e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD4—melanoma	2.46e-06	4.09e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAQ—melanoma	2.44e-06	4.05e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CD44—melanoma	2.44e-06	4.05e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAQ—melanoma	2.42e-06	4.02e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CD44—melanoma	2.42e-06	4.02e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLA2G6—melanoma	2.4e-06	3.98e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—melanoma	2.39e-06	3.97e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—melanoma	2.39e-06	3.97e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.37e-06	3.93e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—melanoma	2.36e-06	3.93e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.35e-06	3.9e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—melanoma	2.34e-06	3.89e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—melanoma	2.34e-06	3.89e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1B1—melanoma	2.34e-06	3.89e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1B1—melanoma	2.32e-06	3.85e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—melanoma	2.32e-06	3.85e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—melanoma	2.31e-06	3.84e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—melanoma	2.3e-06	3.82e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—melanoma	2.3e-06	3.81e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—melanoma	2.29e-06	3.8e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—melanoma	2.28e-06	3.79e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—melanoma	2.27e-06	3.78e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—melanoma	2.27e-06	3.77e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—melanoma	2.27e-06	3.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—melanoma	2.26e-06	3.76e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—melanoma	2.26e-06	3.75e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.24e-06	3.73e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—melanoma	2.19e-06	3.64e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FN1—melanoma	2.18e-06	3.62e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—VCAN—melanoma	2.15e-06	3.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—melanoma	2.14e-06	3.55e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—melanoma	2.14e-06	3.55e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—melanoma	2.13e-06	3.54e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—melanoma	2.13e-06	3.54e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—NFKB1—melanoma	2.12e-06	3.53e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—melanoma	2.11e-06	3.51e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—melanoma	2.09e-06	3.48e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CD80—melanoma	2.09e-06	3.47e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—melanoma	2.08e-06	3.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KIT—melanoma	2.08e-06	3.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APC—melanoma	2.08e-06	3.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGF—melanoma	2.06e-06	3.42e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.05e-06	3.4e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—melanoma	2.03e-06	3.37e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—melanoma	2.02e-06	3.36e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—melanoma	2.01e-06	3.33e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—melanoma	1.99e-06	3.3e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—melanoma	1.97e-06	3.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—melanoma	1.97e-06	3.27e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—melanoma	1.96e-06	3.25e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—melanoma	1.96e-06	3.25e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PRKCA—melanoma	1.93e-06	3.2e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—melanoma	1.93e-06	3.2e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ERCC2—melanoma	1.91e-06	3.18e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—melanoma	1.91e-06	3.17e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—melanoma	1.91e-06	3.17e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1—melanoma	1.91e-06	3.17e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—melanoma	1.9e-06	3.16e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—melanoma	1.89e-06	3.14e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAP2K1—melanoma	1.84e-06	3.06e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—melanoma	1.83e-06	3.04e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK3—melanoma	1.82e-06	3.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP17A1—melanoma	1.82e-06	3.02e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PRKCA—melanoma	1.77e-06	2.94e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—melanoma	1.76e-06	2.93e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ERCC2—melanoma	1.76e-06	2.92e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PRKCA—melanoma	1.76e-06	2.92e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—melanoma	1.76e-06	2.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGF2—melanoma	1.75e-06	2.91e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ERCC2—melanoma	1.74e-06	2.9e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK1—melanoma	1.73e-06	2.88e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—melanoma	1.73e-06	2.88e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—melanoma	1.73e-06	2.88e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—melanoma	1.72e-06	2.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNA11—melanoma	1.72e-06	2.85e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—melanoma	1.7e-06	2.82e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK3—melanoma	1.68e-06	2.8e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—FASN—melanoma	1.68e-06	2.79e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—melanoma	1.65e-06	2.74e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—melanoma	1.64e-06	2.72e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—melanoma	1.64e-06	2.72e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—melanoma	1.64e-06	2.72e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—melanoma	1.62e-06	2.69e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK1—melanoma	1.6e-06	2.66e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—melanoma	1.6e-06	2.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—melanoma	1.6e-06	2.65e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAQ—melanoma	1.6e-06	2.65e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CD44—melanoma	1.6e-06	2.65e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.58e-06	2.63e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—melanoma	1.53e-06	2.55e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1B1—melanoma	1.53e-06	2.54e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—melanoma	1.51e-06	2.51e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—melanoma	1.51e-06	2.51e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—melanoma	1.5e-06	2.5e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—melanoma	1.5e-06	2.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—melanoma	1.5e-06	2.49e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—melanoma	1.49e-06	2.47e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—melanoma	1.47e-06	2.44e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—melanoma	1.47e-06	2.43e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—melanoma	1.46e-06	2.42e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-06	2.4e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—melanoma	1.43e-06	2.37e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—melanoma	1.42e-06	2.35e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—melanoma	1.39e-06	2.31e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—melanoma	1.39e-06	2.31e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—melanoma	1.39e-06	2.31e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—melanoma	1.39e-06	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—melanoma	1.38e-06	2.3e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—melanoma	1.38e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—melanoma	1.38e-06	2.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKB1—melanoma	1.37e-06	2.28e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—melanoma	1.34e-06	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—melanoma	1.33e-06	2.21e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—melanoma	1.33e-06	2.21e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—melanoma	1.33e-06	2.2e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—melanoma	1.31e-06	2.18e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—melanoma	1.3e-06	2.15e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—melanoma	1.29e-06	2.14e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—melanoma	1.26e-06	2.09e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—melanoma	1.25e-06	2.07e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—melanoma	1.23e-06	2.05e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—melanoma	1.23e-06	2.04e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—melanoma	1.23e-06	2.04e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—melanoma	1.23e-06	2.04e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—melanoma	1.22e-06	2.03e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—melanoma	1.22e-06	2.03e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—melanoma	1.21e-06	2.01e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—melanoma	1.21e-06	2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—melanoma	1.19e-06	1.98e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK3—melanoma	1.18e-06	1.96e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRKCA—melanoma	1.16e-06	1.93e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—melanoma	1.16e-06	1.92e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ERCC2—melanoma	1.15e-06	1.91e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—melanoma	1.15e-06	1.9e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—melanoma	1.15e-06	1.9e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—melanoma	1.14e-06	1.89e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK1—melanoma	1.12e-06	1.86e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—melanoma	1.12e-06	1.86e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—melanoma	1.06e-06	1.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—melanoma	1.06e-06	1.76e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—melanoma	1.05e-06	1.75e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—melanoma	1.05e-06	1.75e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—melanoma	1.05e-06	1.74e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—melanoma	1e-06	1.66e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—melanoma	9.99e-07	1.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—melanoma	9.73e-07	1.62e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—melanoma	9.41e-07	1.56e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—melanoma	9.2e-07	1.53e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—melanoma	9.14e-07	1.52e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—melanoma	9.12e-07	1.51e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—melanoma	9.08e-07	1.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—melanoma	9e-07	1.5e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—melanoma	8.76e-07	1.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—melanoma	8.62e-07	1.43e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—melanoma	7.98e-07	1.33e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—melanoma	7.95e-07	1.32e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—melanoma	7.88e-07	1.31e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—melanoma	7.47e-07	1.24e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—melanoma	7.05e-07	1.17e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—melanoma	6.96e-07	1.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—melanoma	6.89e-07	1.15e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—melanoma	6.49e-07	1.08e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—melanoma	6.43e-07	1.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—melanoma	6.01e-07	9.99e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—melanoma	5.76e-07	9.57e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—melanoma	5.3e-07	8.8e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—melanoma	5.25e-07	8.73e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—melanoma	4.24e-07	7.04e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—melanoma	3.46e-07	5.75e-06	CbGpPWpGaD
